These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 20224468

  • 1. Posterior uveal melanoma in young patients treated with proton beam therapy.
    Vavvas D, Kim I, Lane AM, Chaglassian A, Mukai S, Gragoudas E.
    Retina; 2010 Sep; 30(8):1267-71. PubMed ID: 20224468
    [Abstract] [Full Text] [Related]

  • 2. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO).
    Dendale R, Lumbroso-Le Rouic L, Noel G, Feuvret L, Levy C, Delacroix S, Meyer A, Nauraye C, Mazal A, Mammar H, Garcia P, D'Hermies F, Frau E, Plancher C, Asselain B, Schlienger P, Mazeron JJ, Desjardins L.
    Int J Radiat Oncol Biol Phys; 2006 Jul 01; 65(3):780-7. PubMed ID: 16647221
    [Abstract] [Full Text] [Related]

  • 3. Proton beam radiotherapy for uveal melanomas at nice teaching hospital: 16 years' experience.
    Caujolle JP, Mammar H, Chamorey E, Pinon F, Herault J, Gastaud P.
    Int J Radiat Oncol Biol Phys; 2010 Sep 01; 78(1):98-103. PubMed ID: 19910136
    [Abstract] [Full Text] [Related]

  • 4. Survival after proton-beam irradiation of uveal melanomas.
    Kodjikian L, Roy P, Rouberol F, Garweg JG, Chauvel P, Manon L, Jean-Louis B, Little RE, Sasco AJ, Grange JD.
    Am J Ophthalmol; 2004 Jun 01; 137(6):1002-10. PubMed ID: 15183783
    [Abstract] [Full Text] [Related]

  • 5. Long-term follow-up after uveal melanoma charged particle therapy.
    Char DH, Kroll SM, Castro J.
    Trans Am Ophthalmol Soc; 1997 Jun 01; 95():171-87; discussion 187-91. PubMed ID: 9440169
    [Abstract] [Full Text] [Related]

  • 6. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma.
    Gragoudas ES, Lane AM, Munzenrider J, Egan KM, Li W.
    Trans Am Ophthalmol Soc; 2002 Jun 01; 100():43-8; discussion 48-9. PubMed ID: 12545676
    [Abstract] [Full Text] [Related]

  • 7. Proton therapy of uveal melanomas in Berlin. 5 years of experience at the Hahn-Meitner Institute.
    Höcht S, Bechrakis NE, Nausner M, Kreusel KM, Kluge H, Heese J, Heufelder J, Cordini D, Homeyer H, Fuchs H, Martus P, Foerster MH, Wiegel T, Hinkelbein W.
    Strahlenther Onkol; 2004 Jul 01; 180(7):419-24. PubMed ID: 15241529
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Variates of survival in metastatic uveal melanoma.
    Rietschel P, Panageas KS, Hanlon C, Patel A, Abramson DH, Chapman PB.
    J Clin Oncol; 2005 Nov 01; 23(31):8076-80. PubMed ID: 16258106
    [Abstract] [Full Text] [Related]

  • 11. Local recurrence after uveal melanoma proton beam therapy: recurrence types and prognostic consequences.
    Caujolle JP, Paoli V, Chamorey E, Maschi C, Baillif S, Herault J, Gastaud P, Hannoun-Levi JM.
    Int J Radiat Oncol Biol Phys; 2013 Apr 01; 85(5):1218-24. PubMed ID: 23177670
    [Abstract] [Full Text] [Related]

  • 12. Proton therapy for uveal melanoma in 43 juvenile patients: long-term results.
    Petrovic A, Bergin C, Schalenbourg A, Goitein G, Zografos L.
    Ophthalmology; 2014 Apr 01; 121(4):898-904. PubMed ID: 24405742
    [Abstract] [Full Text] [Related]

  • 13. Uveal melanoma recurrence after fractionated proton beam therapy: comparison of survival in patients treated with reirradiation or with enucleation.
    Marucci L, Ancukiewicz M, Lane AM, Collier JM, Gragoudas ES, Munzenrider JE.
    Int J Radiat Oncol Biol Phys; 2011 Mar 01; 79(3):842-6. PubMed ID: 20472356
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Proton beam therapy for the treatment of uveal melanoma in Scotland.
    Macdonald EC, Cauchi P, Kemp EG.
    Br J Ophthalmol; 2011 Dec 01; 95(12):1691-5. PubMed ID: 21216794
    [Abstract] [Full Text] [Related]

  • 16. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
    Conway RM, Poothullil AM, Daftari IK, Weinberg V, Chung JE, O'Brien JM.
    Arch Ophthalmol; 2006 Jun 01; 124(6):838-43. PubMed ID: 16769837
    [Abstract] [Full Text] [Related]

  • 17. Conservation treatment of the eye: Conformal proton reirradiation for recurrent uveal melanoma.
    Marucci L, Lane AM, Li W, Egan KM, Gragoudas ES, Adams JA, Collier JM, Munzenrider JE.
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1018-22. PubMed ID: 16376492
    [Abstract] [Full Text] [Related]

  • 18. 125I plaque therapy for uveal melanoma. Analysis of the impact of time and dose factors on local control.
    Quivey JM, Augsburger J, Snelling L, Brady LW.
    Cancer; 1996 Jun 01; 77(11):2356-62. PubMed ID: 8635107
    [Abstract] [Full Text] [Related]

  • 19. Uveal melanoma: proton beam irradiation.
    Gragoudas ES, Marie Lane A.
    Ophthalmol Clin North Am; 2005 Mar 01; 18(1):111-8, ix. PubMed ID: 15763196
    [Abstract] [Full Text] [Related]

  • 20. Proliferative radiation retinopathy after plaque radiotherapy for uveal melanoma.
    Bianciotto C, Shields CL, Pirondini C, Mashayekhi A, Furuta M, Shields JA.
    Ophthalmology; 2010 May 01; 117(5):1005-12. PubMed ID: 20079924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.